You are here:
Dear Doctor Letter (Rote-Hand-Brief) on Valproat: new restrictions on use; pregnancy prevention program to be put in place
2018.11.09
Active substance: valproate
Marketing authorization holders of valproate-containing drugs inform about important new contraindications, strengthened warnings and measures to prevent valproate exposure during pregnancy.
Schulungsmaterial (Educational material - available in German only)
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN